Skip to main content

Table 1 Baseline characteristics of the included subjects

From: Different Methods for Measurements and Estimation of Pulse Wave Velocity are not Interchangeable

 

Mean value ± SD;

f (N%)

Median (Min–Max);

f (N%)

Gender (male)

107 (69.5%)

 

Age (years)

38.75 ± 12.65

37.5 (20–74)

Body mass index (BMI) (kg/m2)

28.51 ± 4.22

27.76 (20.01–41.45)

Body mass index (categories)

Underweight

(BMI < 18.5)

0 (0%)

Normal weight

(BMI: 18.5–24.9)

31 (20.1%)

Overweight

(BMI: 25–29.9)

75 (48.7%)

Obesity

(BMI > 30)

48 (31.2%)

Body surface area(m2)

2.11 ± 0.22

2.14 (1.43–2.62)

Waist circumference (cm)

93.14 ± 12.87

94 (56–123)

Systolic blood pressure office (mmHg)

141.15 ± 10.87

140 (119–174)

Diastolic blood pressure office (mmHg)

87.34 ± 7.9

87 (67–110)

Heart rate (bites/min)

79.97 ± 10.39

79 (56–111)

Smoking

Yes

57 (37%)

Ex-smoker

30 (19.5%)

Never smoker

67 (43.5%)

Term of birth

Preterm (before the 37th gestational week)

39 (25.5%)

Term (in the 37th -42nd gestational week)

109 (71.2%)

Post term (after the 42nd gestational week)

5 (3.3%)

Birth weight (g)

3106.64 ± 683.45

3200 (1450–5000)

Number of days before term of birth

28.08 ± 2.47

28 (23–32)

AH in family (yes)

138 (89.6%)

 

CVD in family (yes)

100 (65.4%)

 

Cerebrovascular disease in family (yes)

47 (30.7%)

 

Kidney diseases -family (Yes)

22 (14.3%)

 

Death of CVD family (yes)

52 (33.8%)

 

Death of Cerebrovascular disease in family (yes)

25 (16.2%)

 

Antihypertensive drugs (yes)

143 (92.8%)

 

RAAS inhibitors (yes)

115 (74.7%)

 
  1. CVD cardiovascular diseases, RAAS renin-angiotensin-aldosterone system, AH arterial hypertension